Charles S. Fuchs

Charles S. Fuchs is an American oncologist. From 2016 to 2021 he was director of the Yale Cancer Center in New Haven, Connecticut, Sackler professor of medicine at the Yale School of Medicine,[1] and physician-in-chief of the Smilow Cancer Hospital.[2] He left Yale to work for the Hoffman-La Roche group of companies.[3] From 1987 to 1993 he was a resident at Brigham and Women’s Hospital.[4]

Charles S. Fuchs

He has worked on gastrointestinal cancers and on cancer epidemiology,[5] and has published results of research on colorectal cancer.[6][7]

References
  1. "Fuchs to lead Cancer Center". yaledailynews.com. 7 October 2016.
  2. "Charles S. Fuchs, MD, MPH, to Lead Yale Cancer Center and Smilow Cancer Hospital".
  3. [s.n.] (15 January 2021). Charles S. Fuchs named SVP at Roche and Genentech. The Cancer Letter. Accessed March 2021.
  4. "Charles S. Fuchs, MD, MPH - DFCI Master Class".
  5. "Charles S. Fuchs, MD, MPH | Giants of Cancer Care". www.giantsofcancercare.com.
  6. Cancer Genome Atlas, Network; et al. (July 2012). "Comprehensive molecular characterization of human colon and rectal cancer". Nature. 487 (7407): 330–7. Bibcode:2012Natur.487..330T. doi:10.1038/nature11252. PMC 3401966. PMID 22810696.
  7. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (January 2004). "A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer". J. Clin. Oncol. 22 (1): 23–30. doi:10.1200/JCO.2004.09.046. PMID 14665611.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.